Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

PACB Relative to the S&P 500

PACB Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Pacific Biosciences of California Inc. (NASD:PACB) seasonal charts above shows that a Buy Date of July 20 and a Sell Date of October 15 has resulted in a geometric average return of 10.58% above the benchmark rate of the S&P 500 Total Return Index over the past 13 years. This seasonal timeframe has shown positive results compared to the benchmark in 10 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 13 years by an average of 36.68% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company’s revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

To download PACB seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: PACB